Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..
Clinical trial NCT05955183 · COMPLETED
Trial details
- NCT number
- NCT05955183
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-27
- Primary completion
- 2023-12-04
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.